Trials / Not Yet Recruiting
Not Yet RecruitingNCT07258173
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita: a Phase II, Randomized, Double Blind, Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Jennifer Keiser · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to compare the efficacy and safety of emodepside, with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Emodepside | Treatment with 15 mg of emodepside |
| DRUG | Albendazole 400 mg | Treatment with 400mg of albendazole |
Timeline
- Start date
- 2026-01-15
- Primary completion
- 2026-05-15
- Completion
- 2026-05-15
- First posted
- 2025-12-02
- Last updated
- 2025-12-02
Source: ClinicalTrials.gov record NCT07258173. Inclusion in this directory is not an endorsement.